Respiratory Syncytial Virus Disease and RSV Vaccine
This information paper describes respiratory syncytial virus disease and the vaccines to prevent it.
This website has recently undergone changes. As a result, the website is experiencing intermittent interruptions. We're aware of this issue and we're working to resolve these issues. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.
Learn more about the Freedom of Information Act (FOIA) Reading Room, which is part of the 1996 amendments to FOIA, mandating publicly accessible "electronic reading rooms" with agency FOIA response materials and other information routinely available to the public.
Please note that files more than five years old may not be compliant with Section 508 of the Rehabilitation Act. If you need an accessible version of a particular file, please contact us and we will provide one for you.
We found 715 items
This information paper describes respiratory syncytial virus disease and the vaccines to prevent it.
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Novavax COVID-19 Vaccine, for active immunization to prevent COVID-19 in individuals 12 years of age and older.
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Novavax COVID-19 Vaccine, for active immunization to prevent COVID-19 in individuals 12 years of age and older.
Low-level blast is defined as blast generated from firing heavy weapon systems or explosives in combat or training environments. Exposure to low-level blast does not typically result in a clinically diagnosable concussion, also known as mild traumatic brain injury. TBICoE developed this fact sheet for DOD health care providers.
An information paper that describes COVID-19 disease and the vaccines that are used for protection.
Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization of Pfizer-BioNTech COVID-19 Vaccine (2024-2025 formulation)
Fact Sheet for Recipients and Caregivers about Moderna COVID-19 Vaccine (2024-2025 formulation)
Fact Sheet for Recipients and Caregivers about Pfizer-BioNTech COVID-19 Vaccine (2024-2025 formulation)
Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization of Moderna COVID-19 Vaccine (2024-2025 formulation)
The DHMSM Program Management Office oversees deployment, operations, and sustainment of MHS GENESIS®. DHMSM manages the acquisition, testing, delivery, integration, and successful operation and sustainment of MHS GENESIS, a state-of-the-market electronic health record and health care system solution that transforms the way the Department of Defense ...
MHS GENESIS THEATER provides Role 3 operational medicine sites with a robust electronic health record solution for management and documentation of patient care.
Medical Common Operating Picture is the joint system of record and an interactive platform that enables medical command and control/medical situational awareness decision making, by leveraging enhanced digital tools to analyze and visualize data from the tactical to strategic levels. MedCOP facilitates real-time operational medicine information ...
MHS GENESIS is the Department of Defense's new electronic health record. When fully deployed, MHS GENESIS will provide the DOD's 9.6 million beneficiaries and 205,000 medical providers with a single, integrated health record across the continuum of care – deployed and at home and eventually, through the transition to the Department of Veterans Affairs.
The purpose of this information paper is to describe influenza disease and supporting vaccines to prevent its spread.
The Medical Simulation and Training PMO serves as the materiel developer and total lifecycle systems manager for medical simulation and training products across the Military Health System.
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil View the external links disclaimer.